12. Data valuation for regulated industries like finance or healthcare

Finance and healthcare operate under some of the strictest regulatory frameworks in the modern economy. These industries handle vast amounts of sensitive information daily, from patient records and clinical data to transaction histories and credit profiles. Yet despite the obvious importance of this data to their core operations, most regulated firms struggle to articulate its financial worth in concrete terms. Data valuation in these sectors is not just an accounting exerciseit directly influences strategic decisions about compliance investments, technology upgrades, partnerships, and even mergers.

The challenge for regulated industries is that their data carries both exceptional value and exceptional responsibility. A bank's customer transaction data can reveal spending patterns that drive personalized services and risk models, but it must be protected under financial privacy laws. Similarly, a hospital's anonymized patient outcomes data could accelerate medical research and improve care pathways, yet it remains bound by health information regulations. Traditional valuation methods often fail to capture this dual nature. Cost-based approaches underestimate strategic potential, while market-based comparisons struggle with the limited examples of compliant data sales or licensing. The result is that boards and executives lack a reliable figure when weighing data-driven opportunities against regulatory risk.

Proper data valuation helps regulated organizations make better decisions within their constraints. When a financial institution knows the value of its proprietary credit data, it can justify investments in data quality, cybersecurity, and governance frameworks with measurable returns. Healthcare providers that quantify the worth of their clinical datasets can negotiate more effectively with research partners or prioritize which data streams to collect and maintain. Valuation also supports regulatory conversations: demonstrating to auditors and regulators that data is treated as a valuable asset reinforces a culture of protection and accountability. It transforms data governance from a compliance burden into a value-preserving discipline.

As regulators worldwide begin to recognize data as a critical economic asset, they are likely to demand greater transparency in how it is managed and valued. Industries that establish credible valuation practices now will be better prepared for future reporting requirements and more confident in their data strategies. For finance and healthcare, where trust and compliance are non-negotiable, valuing data properly is not just good businessit is becoming a necessary foundation for sustainable growth.